Aller au contenu principal

Organ Modelling Congress

Published by Vibiosphen - 13 April 2022


Our Organ Modelling Congress addresses an important and expanding field which provides new understandings in organ functionality and novel approaches to drug
development. These engineered human organs using Organ-on-a-Chip, Tissue-on-a-Chip & Organoids are a remarkable tool with the potential to facilitate studies that
better predict drug efficacy and thereby reduce cost, time, and failure rates in clinical trials. Further, patient-derived organoids hold promise for personalised medicine,
as they have the potential to produce individualised predictions of drug response.

Vibiosphen will be present at the congress in order to improve our predictive model and to lead our innovation in the field of organoids. 


Image de la news